LobbyingZynerba Pharmaceuticals lobbying by quarter
Zynerba Pharmaceuticals's latest lobbying report covers Q4 2023, at $5,000. Its first report covers Q4 2022; the issues it reports most are Government Issues and Health Issues.
Zynerba Pharmaceuticals
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $15K | 1 |
| Q1 2023 | $15K | 1 |
| Q2 2023 | $45K | 1 |
| Q3 2023 | $45K | 1 |
| Q4 2023 | $5,000 | 1 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Government issues$40K · 4 reports
- Health issues$40K · 4 reports
- Pharmacy$40K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Watkins & Eager PLLC | $125K | 5 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| GREGG L HARPER | Former Member of U.S. House of Representatives | Q3 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/01/08for Q4 2023 | Watkins & Eager PLLC | $5,000 |
| 23/10/04for Q3 2023 | Watkins & Eager PLLC | $45K |
| 23/07/18for Q2 2023 | Watkins & Eager PLLC | $45K |
| 23/04/05for Q1 2023 | Watkins & Eager PLLC | $15K |
| 23/01/09for Q4 2022 | Watkins & Eager PLLC | $15K |